SP

SPRUCE BIOSCIENCES INC

SPRB·85209E208·US·Common Stock·Healthcare - Biotechnology-Activist

SPRB (SPRUCE BIOSCIENCES INC) is held by 15 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($7.3M), CITADEL ADVISORS LLC ($4.6M), Alyeska Investment Group, L.P. ($3.4M). Net institutional sentiment: Mixed.

15
Holders
$28.1M
Total Value
40% (15)
Consensus
6 buying - 9 selling
13F: Insider & Congress:
SPSmart Money Verdict
View all
Held by 15 funds
Who's Trading
ActivistAIAlyeska Investment Group, L.P.4.5%May 15, 2026
ActivistWellington Management Group LLPWellington Management Group LLP3.6%May 15, 2026
ActivistKenneth GriffinKenneth Griffin5.1%May 15, 2026
ActivistSMSquadron Master Fund LP0.9%May 15, 2026
ActivistIKIkarian Capital, LLC4.8%May 7, 2026
ActivistExodusPoint Capital Management, LPExodusPoint Capital Management, LP0.8%Apr 28, 2026
ActivistICIntegrated Core Strategies (US) LLC9.6%Feb 24, 2026
InsiderPLParkman Healthcare Partners LLCBuy $5KOct 6, 2025
InsiderPLParkman Healthcare Partners LLCSell $4KOct 6, 2025
InsiderPLParkman Healthcare Partners LLCSell $436.393Oct 6, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
111,888$7.3M0.0%-10.32%
38
Unchanged
69,999$4.6M0.0%-39.43%
0
Unchanged
51,671$3.4M0.0%-39.43%
0
Decreased
48,796(-17.2%)$3.2M0.0%-39.43%
0
Unchanged
40,000$2.6M0.0%-39.43%
0
Unchanged
38,620$2.5M0.0%+416.19%
0
Decreased
22,000(-12.9%)$1.4M0.0%-39.43%
0
Unchanged
16,938$1.1M0.0%-39.43%
0
Increased
12,889(+1.2%)$842,7290.0%-39.19%
25
New
5,506$359,8170.0%-10.32%
36
Decreased
5,400(-15.6%)$352,8900.0%-39.43%
0
Decreased
3,919(-20.1%)$256,1070.0%-37.96%
0
Increased
1,415(+264.7%)$92,4710.0%-13.87%
24
New
939$61,3640.0%-10.32%
32
Increased
193(+129.8%)$12,1670.0%-25.84%
19
Exited
0(-100.0%)$210,9800.0%-32.47%
0
Exited
0(-100.0%)$3,0000.0%-32.47%
0
Exited
0(-100.0%)$2.2M0.0%-32.47%
0
Exited
0(-100.0%)$8,1010.0%-30.49%
0
Exited
0(-100.0%)$174,2200.0%-32.47%
0

Showing 1-20 of 20

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used